Genetic polymorphism of organic cation transporter 2 (OCT2) and its effects on the pharmacokinetics and pharmacodynamics of Metformin: a narrative review

Genetic polymorphism of organic cation transporter 2 (OCT2) and its effects on the pharmacokinetics and pharmacodynamics of Metformin: a narrative review

Abstract Background Organic cation transporter 2 (OCT2) is a renal carrier transporter protein found in the basolateral membrane of proximal epithelial cells, which facilitates active secretion of Metformin. The genetic polymorphism of OCT2 influences the pharmacodynamic and pharmacokinetic effect o...

Full description

Bibliographic Details
Main Authors:	Swathi Swaroopa Borra, Niva Rose Jane, Dhivyaprasath Palaniappan, Rupakrishnan Subramanian, Mithila Amar Patankar, Sadagoban Gopal Krishnamoorthy, Arun Kanniyappan Parthasarathy
Format:	Article
Language:	English
Published:	SpringerOpen 2023-01-01
Series:	Egyptian Journal of Medical Human Genetics
Subjects:	Genetic polymorphism OCT2 SLC22A2 Substrate drugs Metformin Type 2 diabetes mellitus (T2DM)
Online Access:	https://doi.org/10.1186/s43042-023-00388-z

Similar Items

The effect of OCT-2 inhibitor Daclatasvir on Metformin pharmacokinetics and pharmacodynamics at two dose levels: A Bayesian approach using Markov-Chain Monte Carlo simulations
by: Mohamed Raslan, et al.
Published: (2022-12-01)

PHARMACOGENETICS OF ORGANIC CATION TRANSPORTERS
by: V. A. Evteev, et al.
Published: (2018-06-01)

Pharmacodynamic Modeling to Evaluate the Impact of Cimetidine, an OCT2 Inhibitor, on the Anticancer Effects of Cisplatin
by: Hardik Mody, et al.
Published: (2022-12-01)

Metformin: Ongoing Journey with Superdrug Revolution
by: Amr Ahmed EL-Arabey, et al.
Published: (2019-02-01)

Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in <i>Human</i> and <i>Mouse</i> Organic Cation Transporter OCT2
by: Annett Kuehne, et al.
Published: (2022-12-01)

PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice
by: Adriano Cleis Arruda, et al.
Published: (2020-01-01)

Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
by: Fizalah Kawoosa, et al.
Published: (2022-05-01)

Effects of naringenin on renal expression of organic cation transporter 1 and 2 proteins and metformin disposition in diabetic rats
by: Edith Pascale Mofo Mato, et al.
Published: (2019-08-01)

Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration
by: Igor B. Nazarov, et al.
Published: (2024-01-01)

Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol
by: Edith Pascale Mofo Mato, et al.
Published: (2018-07-01)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
by: Darren eMoss, et al.
Published: (2015-04-01)

Expression of SOX2 and OCT4 in odontogenic cysts and tumors
by: Ekarat Phattarataratip, et al.
Published: (2021-07-01)

Enforcement of developmental lineage specificity by transcription factor Oct1
by: Zuolian Shen, et al.
Published: (2017-05-01)

Exogenous OCT4 and SOX2 Contribution to In Vitro Reprogramming in Cattle
by: Lucas Simões Machado, et al.
Published: (2023-09-01)

Significance of OCT3/4 and SOX2 antigens expression by leukemic blast cells in adult acute leukemia
by: Salah Aref, et al.
Published: (2024-02-01)

Cloning and Functional Characterization of Dog OCT1 and OCT2: Another Step in Exploring Species Differences in Organic Cation Transporters
by: Marleen Julia Meyer, et al.
Published: (2022-05-01)

En face OCT
by: Andre Romano, et al.
Published: (2014-04-01)

Expression patterns of OCT4, NANOG, and SOX2 in goat preimplantation embryos from in vivo and in vitro
by: Xiao-li YU, et al.
Published: (2015-07-01)

Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates
by: Maarten van der Velden, et al.
Published: (2017-10-01)

A systematic review of OCT and OCT angiography in retinal vasculitis
by: Dhanach Dhirachaikulpanich, et al.
Published: (2023-01-01)

rs622342 in <i>SLC22A1</i>, <i>CYP2C9</i>*2 and <i>CYP2C9</i>*3 and Glycemic Response in Individuals with Type 2 Diabetes Mellitus Receiving Metformin/Sulfonylurea Combination Therapy: 6-Month Follow-Up Study
by: Khaled Naja, et al.
Published: (2020-06-01)

Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2)
by: Max Maane, et al.
Published: (2023-03-01)

Using the [Co(oct)2] as a New Precursor for Simple Synthesis of CoS2 Nanoparticles and Kinetics Studies on Photocatalytic Activities Under UV Irradiation
by: Faezeh Soofivand, et al.
Published: (2018-01-01)

OCT1 Polyspecificity—Friend or Foe?
by: Marleen J. Meyer, et al.
Published: (2021-06-01)

Studying the expression patterns of OCT4 and SOX2 proteins in regenerating rabbit ear tissue
by: A. S. Javanmard, et al.
Published: (2016-06-01)

Effect of Metformin on Glycemic Control Regarding Carriers of the SLC22A1/OCT1 (rs628031) Polymorphism and Its Interactions with Dietary Micronutrients in Type 2 Diabetes
by: Zepeda-Carrillo EA, et al.
Published: (2022-06-01)

Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression
by: Nicola Morrice, et al.
Published: (2023-11-01)

Organic Cation Transporters (OCTs) in EpiAirway™, a Cellular Model of Normal Human Bronchial Epithelium
by: Amelia Barilli, et al.
Published: (2020-05-01)

Oct2 and Obf1 as facilitators of B:T cell collaboration during a humoral immune response
by: Lynn M Corcoran, et al.
Published: (2014-03-01)

OCT4 Represses Inflammation and Cell Injury During Orchitis by Regulating CIP2A Expression
by: Ruifeng Zeng, et al.
Published: (2021-08-01)

Association between the synonymous variant organic cation transporter 3 (OCT3)-1233G>A and the glycemic response following metformin therapy in patients with type 2 diabetes
by: Seyyedeh Raheleh Hosseyni-Talei, et al.
Published: (2017-03-01)

Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
by: Qianying Zhu, et al.
Published: (2019-08-01)

A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications
by: Resia Varghese, et al.
Published: (2023-01-01)

Endogenous fluctuations of OCT4 and SOX2 bias pluripotent cell fate decisions
by: Daniel Strebinger, et al.
Published: (2019-09-01)

Impact of Placental SLC2A3 Deficiency during the First-Half of Gestation
by: Cameron S. Lynch, et al.
Published: (2022-10-01)

Progress on the role of ABCG2 and SLC2A9 in the onset of hyperuricemia and gout
by: YANG Lijuan, DONG Qiumei, WU Hao
Published: (2023-09-01)

Slc2a6 regulates myoblast differentiation by targeting LDHB
by: Xuan Jiang, et al.
Published: (2022-07-01)

Alanine–Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells
by: Peng Ye, et al.
Published: (2022-05-01)

Genetic association of solute carrier transporter gene variants with metformin response
by: Abrahams-October Z, et al.
Published: (2021-07-01)

Effects of Genetic Polymorphism in CYP2D6, CYP2C19, and the Organic Cation Transporter OCT1 on Amitriptyline Pharmacokinetics in Healthy Volunteers and Depressive Disorder Patients
by: Johannes Matthaei, et al.
Published: (2021-05-01)